231
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

An observational study on the incidence of tuberculosis among a cohort of HIV infected adults in a setting with low prevalence of tuberculosis

&

References

  • Horsburgh CR, Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 2004;350(20):2060–2067.10.1056/NEJMsa031667
  • WHO, UNAIDS. Policy Statement on Preventive Therapy against Tuberculosis in People Living with HIV. Geneva: WHO; 1998.
  • Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis in HIV infected persons. Cochrane Database Syst Rev. 2010;1:CD000171.
  • Girardi E, Sabin CA, d’Arminio MA, et al. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis. 2005;41:1772–1782.
  • British HIV Association. British HIV Association guidelines for the treatment of TB/HIV coinfection 2011. HIV Med. 2011;12:517–524.
  • World Health Organization. Guidelines for Intensified Tuberculosis Case-finding and Isoniazid Preventive Therapy for People Living with HIV in Resource Constrained Settings. Geneva: Department of HIV/AIDS, Stop TB Department, World Health Organization; 2010.
  • Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363:1005–1015.10.1056/NEJMoa0907847
  • TEMPRANO ANRS 12136 Study Group. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015;373:808–822.10.1056/NEJMoa1507198.
  • Elzi L, Schlegel M, Weber R, et al. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis. 2007;44:94–102.10.1086/cid.2007.44.issue-1
  • Yirdaw KD, Jerene D, Gashu Z, et al. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia. PLoSOne. 2014;9(8):e104557. 10.1371/journal.pone.0104557.
  • Hermans SM, Kiragga AN, Schaefer P, Kambugu A, Hoepelman AIM, Manabe YC. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban hiv clinic in sub-saharan Africa. PLoSOne. 2010;5(5):e10527.10.1371/journal.pone.0010527
  • Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PLoSOne. 2012;7(3):e34156.10.1371/journal.pone.0034156
  • Dean AG, Sullivan KM, Soe MM. OpenEi: Open source epidemiologic statistics for public health, version 3.03a. www.OpenEpi.com, updated 04/05/2015, Accessed November 11, 2015.
  • Balcha TT, Sturegård E, Winqvist N, et al. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of xpert MTB/RIF compared with smear microscopy and liquid culture. PLoSOne. 2014;9(1):e85478.10.1371/journal.pone.0085478
  • Shea KM, Kammerer JS, Winston CA, Navin TR, Horsburgh CR, Jr. Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup. Am J Epidemiol. 2014;179(2):216–225.10.1093/aje/kwt246
  • Houben RM, Crampin AC, Ndhlovu R, et al. Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection. Int J Tuberc Lung Dis. 2011;15(1):24–31.
  • Li J, Munsiff SS, Tarantino T, Dorsinville M. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City. Int J Infect Dis. 2010;14(4):e292–e297. 10.1016/j.ijid.2009.05.007.
  • van Griensven J, Choun K, Chim B, Thai S, Lorent N, Lynen L. Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy. Trop Med Int Health. 2015;20(12):1823–1831. 10.1111/tmi.12609.
  • Oni T, Tsekela R, Kwaza B, et al. A recent HIV diagnosis is associated with non-completion of isoniazid preventive therapy in an HIV-infected cohort in Cape Town. PLoSOne. 2012;7(12):e52489. 10.1371/journal.pone.0052489.
  • Matteelli A, Casalini C, Raviglione MC, et al. Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy. Am J Respir Crit Care Med. 2000;162(5):1653–1655.10.1164/ajrccm.162.5.9912062
  • van Halsema CL, Fielding KL, Chihota VN, Russell EC, Lewis JJ, Churchyard GJ, et al. Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting. AIDS. 2010;24(7):1051–1055.10.1097/QAD.0b013e32833849df
  • Getahun H, Kittikraisak W, Heilig CM, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med. 2011;8(1):e1000391.10.1371/journal.pmed.1000391
  • Rangaka MX, Wilkinson RJ, Glynn JR, et al. Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic. Clin Infect Dis. 2012;55(12):1698–1706. 10.1093/cid/cis775.
  • Walls T, Shingadia D. The epidemiology of tuberculosis in Europe. Arch Dis Child. 2007;92:726–729.10.1136/adc.2006.102889
  • The INSIGHT START Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373:795–807.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.